Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.
Dirk JägerAileen BergerAlexandra TuchClaudia Luckner-MindenRosa EurichMario HlevnjakAndreas SchneeweissPeter LichterSebastian AulmannClaus-Peter HeusselCarlo FremdRichard HarbottleInka ZörnigPatrick SchmidtPublished in: Clinical and translational medicine (2024)